FORM by GBY vs HealthRX
Two GLP-1 desks, one scoreboard. We put FORM by GBY and HealthRX head-to-head on the published Brief Score — the same six factors, scored the same way.
HealthRX
The verdict
HealthRX takes this head-to-head.
HealthRX scores 86 to 67 on our six-factor Brief Score — A LegitScript-certified, physician-supervised desk (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.
That doesn't make FORM by GBY a bad call — it's best for readers who want the widest single-account menu and are willing to complete intake to learn what the branded and adjacent-care lines actually cost. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| FORM by GBY | HealthRX | |
|---|---|---|
| Brief Score | 67/100 (C) | 86/100 (B) |
| Semaglutide | $299/mo (compounded, no dose tiers published) | $189/mo |
| Tirzepatide | Not disclosed (Zepbound membership offered, drug cost not published) | $349/mo |
| Coverage | 48 states + DC (excludes Alaska, Mississippi) | Not publicly listed |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| On the tracker | Newnew to the tracker, no prior reading | Stableprice stable |
FORM by GBY: First reading — one real price (compounded sema $299); everything else, including the advertised Wegovy "$95," is a membership fee or undisclosed.
HealthRX: Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.